Catheter Precision (VTAK) Projected to Post Quarterly Earnings on Thursday

Catheter Precision (NYSEAMERICAN:VTAK) is projected to post its quarterly earnings results on Thursday, March 27th. Analysts expect Catheter Precision to post earnings of ($0.20) per share and revenue of $0.28 million for the quarter.

Catheter Precision Stock Down 2.0 %

Catheter Precision stock opened at $0.39 on Thursday. Catheter Precision has a twelve month low of $0.30 and a twelve month high of $8.40. The stock’s 50 day moving average is $0.41. The company has a quick ratio of 0.65, a current ratio of 0.66 and a debt-to-equity ratio of 0.12.

About Catheter Precision

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.